• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[冠状动脉支架类型对缺血性心脏病患者生活质量动态的影响]

[Effect of the type of a coronary stent on dynamics of quality of life in patients with ischaemic heart disease].

作者信息

Sukovatykh B S, Sukovatykh M B, Polianskiĭ D V

机构信息

Kursk State Medical University of the RF Ministry of Public Health, Kursk, Russia.

出版信息

Angiol Sosud Khir. 2020;26(4):43-48. doi: 10.33529/ANGIO2020426.

DOI:10.33529/ANGIO2020426
PMID:33332305
Abstract

The purpose of the present study was to investigate the dynamics of quality of life in patients with ischaemic heart disease before and after implantation of a coronary stent depending on the stent's type and patient's gender. The authors analysed the dynamics of quality of life in a total of 120 patients with ischaemic heart disease. The patients were subdivided into two equal groups of 60 each. Group One patients were subjected to implantation of bare-metal stents, whereas Group Two patients received stents coated with zotarolimus as an antiproliferative agent. The control group was composed of 60 people who did not suffer from ischaemic heart disease and were comparable by the age and gender. Quality of life was investigated prior to stent implantation and 6, 12 and 24 months thereafter with the use of the SF-36 questionnaire. It was determined that the indices of quality of life before stenting of coronary arteries was higher in men than in women. However, no gender-related differences were revealed after stent implantation. The dynamics of the parameters of quality of life of patients following implantation of uncoated metal stents within 6 months turned out to have a positive and then rapidly progressing negative course, whereas implantation of stents coated with antiproliferative drug zotarolimus was within 12 months followed and accompanied by a positive and then slowly progressing negative course.

摘要

本研究的目的是根据冠状动脉支架类型和患者性别,调查缺血性心脏病患者在植入冠状动脉支架前后的生活质量动态变化。作者分析了总共120例缺血性心脏病患者的生活质量动态变化。患者被平均分为两组,每组60人。第一组患者接受裸金属支架植入,而第二组患者接受涂有抗增殖药物佐他莫司的支架植入。对照组由60名未患缺血性心脏病且在年龄和性别上具有可比性的人组成。在支架植入前以及植入后6、12和24个月,使用SF-36问卷对生活质量进行调查。结果发现,冠状动脉支架植入前男性的生活质量指数高于女性。然而,支架植入后未发现与性别相关的差异。未涂层金属支架植入后6个月内患者生活质量参数的动态变化呈先正后迅速恶化的趋势,而植入涂有抗增殖药物佐他莫司的支架后12个月内,生活质量呈先正后缓慢恶化的趋势。

相似文献

1
[Effect of the type of a coronary stent on dynamics of quality of life in patients with ischaemic heart disease].[冠状动脉支架类型对缺血性心脏病患者生活质量动态的影响]
Angiol Sosud Khir. 2020;26(4):43-48. doi: 10.33529/ANGIO2020426.
2
Comparison of efficacy of low- (80 mg/day) and high- (160-320 mg/day) dose valsartan in the prevention of in-stent restenosis after implantation of bare-metal stents in type B2/C coronary artery lesions.低剂量(80毫克/天)和高剂量(160 - 320毫克/天)缬沙坦预防B2/C型冠状动脉病变裸金属支架植入术后支架内再狭窄的疗效比较。
Am J Cardiovasc Drugs. 2008;8(2):83-7. doi: 10.1007/BF03256585.
3
Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.在随机比较佐他莫司洗脱和西罗莫司洗脱冠状动脉支架的 1 年与 5 年临床结果差异(SORT OUT III 研究):一项多中心、开放标签、随机优效性试验。
Lancet. 2014 Jun 14;383(9934):2047-2056. doi: 10.1016/S0140-6736(14)60405-0. Epub 2014 Mar 14.
4
Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.经导管载液紫杉醇用于预防支架植入后 native coronary artery lesions 的再狭窄。
Circ Cardiovasc Interv. 2009 Aug;2(4):294-301. doi: 10.1161/CIRCINTERVENTIONS.108.827865.108.827865. Epub 2009 Jul 22.
5
Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.裸金属支架置入术后基于导管的紫杉醇给药与药物洗脱支架在冠状动脉疾病支架内再狭窄高危患者中的比较。
Cardiovasc Revasc Med. 2017 Dec;18(8):596-600. doi: 10.1016/j.carrev.2017.05.018. Epub 2017 May 31.
6
Frequency of coronary artery bypass grafting following implantation of a paclitaxel-eluting or a bare-metal stent into a single coronary artery.在单支冠状动脉植入紫杉醇洗脱支架或裸金属支架后进行冠状动脉旁路移植术的频率。
Am J Cardiol. 2009 Jan 1;103(1):11-6. doi: 10.1016/j.amjcard.2008.08.025. Epub 2008 Oct 23.
7
Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions.完全闭塞的自身冠状动脉原发性支架置入术II(PRISON II):裸金属支架植入与西罗莫司洗脱支架植入治疗冠状动脉完全闭塞的随机对照研究
Circulation. 2006 Aug 29;114(9):921-8. doi: 10.1161/CIRCULATIONAHA.106.613588. Epub 2006 Aug 14.
8
The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform.支架涂层对支架输送性能的影响:使用相同支架平台的药物洗脱支架和裸金属支架的直接随机比较。
Kardiol Pol. 2012;70(10):998-1002.
9
Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).全患者人群行经皮冠状动脉介入治疗后第一代或第二代药物洗脱支架或裸金属支架植入术后 2 年的结果:来自 PRODIGY 研究(支架内内膜增生分级后延长双联抗血小板治疗研究)的预先指定分析。
JACC Cardiovasc Interv. 2014 Jan;7(1):20-8. doi: 10.1016/j.jcin.2013.09.008. Epub 2013 Dec 11.
10
In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter.在西罗莫司洗脱支架远端植入裸金属支架以治疗具有小直径远端血管的长的初发冠状动脉病变时,可抑制支架内再狭窄。
Catheter Cardiovasc Interv. 2013 Nov 15;82(6):E777-87. doi: 10.1002/ccd.24841. Epub 2013 Mar 5.

引用本文的文献

1
lncRNA MALAT1/miR-143 axis is a potential biomarker for in-stent restenosis and is involved in the multiplication of vascular smooth muscle cells.长链非编码RNA MALAT1/微小RNA-143轴是支架内再狭窄的潜在生物标志物,并参与血管平滑肌细胞的增殖。
Open Life Sci. 2021 Dec 20;16(1):1303-1312. doi: 10.1515/biol-2021-0126. eCollection 2021.